3-Aminopperidine-2,6-Dion Hydrochloride CAS 24666-56-6;2686-86-4 Ịdị Ọcha>99.0% Lenalidomide Intermediate Factory
Ruifu Chemical bụ onye na-emepụta 3-Aminopperidine-2,6-Dion Hydrochloride (CAS: 24666-56-6; 2686-86-4) nke nwere oke mma, etiti nke Pomalidomide (CAS: 19171-19-8).Ruifu Chemical nwere ike ịnye nnyefe zuru ụwa ọnụ, ọnụahịa asọmpi, ọrụ magburu onwe ya, obere na nnukwu ọnụọgụ dị.Ịzụta 3-Aminopperidine-2,6-Dion Hydrochloride, Please contact: alvin@ruifuchem.com
| Aha Chemical | 3-Aminopperidine-2,6-Dion Hydrochloride |
| Ụdị okwu | 3-Aminopperidine-2,6-Dion HCl;3-Amino-2,6-Piperidinedione Hydrochloride;2,6-Dioxopiperidine-3-Ammonium chloride |
| Nọmba CAS | 24666-56-6 |
| CAS metụtara | 2686-86-4;25181-50-4 |
| Ọnọdụ Ahịa | N'ọkwa, Mpụta Ihe ruru Tọn |
| Usoro ihe omimi | C5H9ClN2O2 |
| Ibu molekụla | 164.59 |
| Ebe Na-agbaze | 120 ℃ |
| COA & MSDS | Dị |
| Mmalite | Shanghai, China |
| Ụdị | Ruifu Chemical |
| Ihe | Nkọwapụta |
| Ọdịdị | Gbanyụọ-White Crystalline ntụ ntụ |
| Ụzọ ịdị ọcha / nyocha | > 99.0% (HPLC) |
| Mmiri (KF) | <0.50% |
| Ọnwụ na ihicha | <0.50% |
| Ihe fọdụrụ na mgbanye | <0.20% |
| Mgbakọta adịghị ọcha | <1.00% |
| Spectrum infrared | Dabara na Ọdịdị |
| Nlele ọkọlọtọ | Standardkpụrụ ụlọ ọrụ |
| Ojiji | Ọkara nke Lenalidomide (CAS: 191732-72-6) |
ngwugwu: Kalama, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ
Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri
3-Aminopperidine-2,6-Dion Hydrochloride (CAS: 24666-56-6; 2686-86-4) bụ etiti maka ịkwadebe Lenalidomide (CAS: 191732-72-6).Lenalidomide bụ ụdị ọgwụ mgbochi tumor nke ụlọ ọrụ na-emepụta ọgwụ ndị America mepụtara.Ọ nwere ọtụtụ ọrụ dị ka mgbochi tumor, usoro mgbochi na mgbochi angiogenesis.Ọ nwere ike igbochi secretion nke cytokines mkpali, na-amụba secretion nke mpụta ọbara mononuclear mgbochi mkpali cytokines.Ọ nwere ike igbochi uto nke ọtụtụ mkpụrụ ndụ myeloma nke ndị ọrịa na sel MM1S.Ihe ọmụmụ ụlọ ọgwụ na-achịkwa nke abụọ na-eme ka ebe nchekwa dị iche iche na-enyocha nchekwa na ọgwụgwọ nke lenalidomide nke a na-eji maka otutu myeloma.Nsonaazụ nyocha ụlọ ọgwụ na nso nso a na-egosi na lenalidomide ọ bụghị naanị na ọ nwere mmetụta ọgwụgwọ na ọgwụgwọ MDS na MM, kamakwa na ọgwụgwọ myeloma, leukemia, carcinoma metastatic renal cell carcinoma, etuto siri ike, amyloidosis idiopathic generalized amyloidosis na sistemu ọkpụkpụ fibrosis na-arịa ọrịa na-enweghị ụmị.Na Disemba 2005, US Food and Drug Administration (FDA) kwadoro lenalidomide ka e jiri ya na ọgwụgwọ nke myelodysplastic syndrome (MDS).
